Dynavax Technologies (DVAX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

DVAX is expected to report earnings to rise 47.50% to 11 cents per share on October 31

Dynavax Technologies DVAX Stock Earnings Reports

Q3'24

Est.

$0.12

Q2'24

Beat

by $0.02

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.03

Q3'23

Beat

by $0.14

The last earnings report on August 06 showed earnings per share of 7 cents, beating the estimate of 5 cents. With 954.64K shares outstanding, the current market capitalization sits at 1.62B.

View a ticker or compare two or three

Compare

DVAX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DVAX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DVAX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of novel products to prevent and treat infectious diseases

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2100 Powell Street

Phone

+1 510 848-5100

Employees

408

Web

https://www.dynavax.com